McLoughlin Margaret - Insider Non-Derivative Transactions at Quince Therapeutics, Inc. (QNCX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 8, 2023, McLoughlin Margaret's relationship to Quince Therapeutics, Inc. (QNCX) is Director, and currently has 8,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other QNCX insiders.
Data Source: SEC.
McLoughlin Margaret - Insider Non-Derivative Transactions at QNCX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 9, 2023 | P -- (Common Stock) | 8000 | 1.23 | 8000 |